Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
about
Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptorInsensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptorThe anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligandIdentification of receptors and signaling pathways for orphan bone morphogenetic protein/growth differentiation factor ligands based on genomic analysesCloning and characterization of a human type II receptor for bone morphogenetic proteinsBioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoproteaseHuman type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPsAnimal models of ovarian cancerCloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptorThe Discovery and Early Days of TGF-β: A Historical PerspectiveIdentification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptorsMullerian inhibiting substance regulates NFkappaB signaling and growth of mammary epithelial cells in vivoAnti-müllerian hormone: a valuable addition to the toolbox of the pediatric endocrinologistAMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapyConditional deletion of beta-catenin mediated by Amhr2cre in mice causes female infertilityB-vitamin and homocysteine status determines ovarian response to gonadotropin treatment in sheepEndometrial cancer is a receptor-mediated target for Mullerian Inhibiting SubstanceInduction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.Effect of anti-Mullerian hormone in culture medium on quality of mouse oocytes matured in vitroMullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma modelMullerian inhibiting substance acts as a motor neuron survival factor in vitro.Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsMullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretionThe genetics of male undermasculinization.Tissue-engineered cells producing complex recombinant proteins inhibit ovarian cancer in vivoAnti Müllerian Hormone (AMH) level and expression in mural and cumulus cells in relation to age.β-Catenin is essential for Müllerian duct regression during male sexual differentiation.Anti-Müllerian hormone recruits BMPR-IA in immature granulosa cells.Regulation of gonadotropin gene expression by Mullerian inhibiting substance.Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation.The undervirilized male child: endocrine aspects.Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosisDevelopment of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells.
P2860
Q24290737-8B88DE7E-2452-4A13-B09F-C2D53F552F2DQ24304044-7371B8DE-1330-4933-A72E-B698FFDEDE47Q24306670-50BEBCFC-68ED-4C67-BDAA-635C28FD6413Q24310450-B87F3F62-E8E2-4CAD-86D1-94CAFA62897BQ24561622-D4B380F4-24F7-4FE6-A29D-E8062A10DBE5Q24621708-FE9F548F-473F-4D43-81A2-2CA922A6AAFDQ24651958-B566C7C0-CF87-46FF-A991-15145122BA6BQ24791470-648ADF44-4BA6-4421-846F-5F7E9AAF3CCDQ28236304-9B8BCE49-5A24-4D99-8E8F-F660386019B5Q28276556-74FABD70-33E1-4039-AC3C-D8F7E695115DQ28297386-AD862954-7546-4133-99AD-1C9A94F70C47Q28577022-60764E3D-6D50-4681-BD63-D140B601FCEEQ28661014-62E3C604-49C3-4738-883C-0AA433233AD1Q30353654-BBF05A22-EC42-4B9B-AFFA-9BE96FF69765Q33583651-44F4D769-54AC-4D62-87DA-1B26A1BAC3EEQ33583751-7ED671BE-0748-4D2F-8B20-5DF0CD577A78Q33716008-67D1241F-C2F1-456E-8748-7624AD74EE22Q33719519-DD9B86A9-B6A8-4EDD-AA7E-AE3F77019ACDQ33763232-00C5B89A-C5B6-428E-BCDA-196948EE445CQ33927553-4D9E3260-645F-4C7C-B525-60D451F03390Q34132471-79D5A3F6-AB38-4389-8A2C-62A5E45DCBD5Q34246272-D096324F-32C2-4F27-861D-8079B15E3AC0Q34434627-9B9BB65D-1D1E-4366-ADB1-968E22766E9EQ34508533-4BD9E6E6-315F-45E0-B11F-8EA7E90170D9Q34534452-EBDD8DFE-A688-480F-9CE4-98C0B93A14F8Q34713416-E52CFB23-2933-4869-A839-43B612B8016DQ34728091-EB8E3964-0684-4980-8CFC-7E07DE64354CQ34855908-DDF63E45-7B0F-4908-903E-85A86ECD0399Q35060595-537078AA-D0A8-4E4A-A7F9-CAE0BE7454E8Q35234562-2D0C4847-EE94-4BFB-AE46-A4B4E21E2E0FQ35533319-7325AC37-AA07-48C1-9878-3C1EF43D33A6Q35739959-68C92A28-4103-4CC2-B622-49439B6ED5D7Q35746614-CD51FDAF-4A23-4A8C-B049-54079E3A50E2Q35768666-276A401C-002D-4297-BC04-69FBC6BA813AQ35793352-4CADE60C-A07C-4325-B905-950E9E5D567DQ35857103-74C4C098-6067-4528-857E-164A02D11142Q36549993-3F12747E-FC7E-43D1-96B2-AA67633FAF3CQ36553502-AF524291-3AFE-4134-9D5F-AA4B21EF8832Q36637142-3ACA8750-A422-4823-AD75-8DA83D546539Q36702415-2E556A11-5A50-4190-8515-BB0524F670C8
P2860
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@ast
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@en
type
label
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@ast
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@en
prefLabel
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@ast
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@en
P2093
P356
P1476
Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone.
@en
P2093
Carmillo P
di Clemente N
P304
P356
10.1210/ME.8.8.1006
P577
1994-08-01T00:00:00Z